ImmunoGen(IMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMGN ImmunoGen

停牌 04-24 08:27:23 EDT

31.23

+0.00

0.00%

最高31.23	最低31.23	成交量0.00
今开31.23	昨收31.23	日振幅0.00%
总市值87.24亿	流通市值81.51亿	总股本2.79亿
成交额15.18亿	换手率0.00%	流通股本2.61亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMGN","market":"US","secType":"STK","nameCN":"ImmunoGen","latestPrice":31.23,"timestamp":1707512400000,"preClose":31.23,"halted":3,"volume":0,"delay":0,"floatShares":261000000,"shares":279354016,"eps":-0.280028,"marketStatus":"停牌","marketStatusCode":1,"change":0,"latestTime":"04-24 08:27:23 EDT","open":31.23,"high":31.23,"low":31.23,"amount":1518209038.257658,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.280028,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713965400000},"adr":0,"listingDate":627886800000,"adjPreClose":31.23,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/IMGN?invite=TIGER026","defaultTab":"news","newsList":[{"id":"2401955887","title":"BUZZ-Ambrx 生物制药公司因 J&J 宣布收购而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2401955887","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2401955887?lang=zh_cn&edition=full","pubTime":"2024-01-08 21:14","pubTimestamp":1704719643,"startTime":"0","endTime":"0","summary":"    1月8日 - ** Ambrx生物制药公司  的股价在盘前交易中上涨了一倍多，达到27.5美元。** 强生公司  称， ，它已同意以20亿美元收购药物开发商AMAM，以获得其癌症靶向疗法的使用权。** 强生公司将以每股28美元的价格收购Ambrx，与该股上次收盘价相比溢价约105%。** Ambrx正在开发的疗法属于被称为抗体-药物共轭物的药物类别，研究人员将其描述为 \"制导导弹\"，可靶向癌细胞并最大限度地减少对健康组织的损害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2389601864","title":"制药行业重磅交易：艾伯维以87亿美元收购Cerevel","url":"https://stock-news.laohu8.com/highlight/detail?id=2389601864","media":"金十数据","top":-1,"share":"https://www.laohu8.com/m/news/2389601864?lang=zh_cn&edition=full","pubTime":"2023-12-07 11:52","pubTimestamp":1701921163,"startTime":"0","endTime":"0","summary":"艾伯维称，Cerevel“强大的”神经科学产品线有望为其增加改变精神科和神经系统疾病护理标准的药物。艾伯维表示，两家公司的董事会已批准该交易，预计将于2024年中期完成，但仍须获得Cerevel股东的批准并满足其他成交条件。他还称，艾伯维将利用其深厚的商业能力、国际基础设施以及监管和临床专业知识，为Cerevel的资产组合提供巨大的股东价值和数十亿美元的销售潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120711524683db7833&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120711524683db7833&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2389069686","title":"独家-艾伯维接近以约 80 亿美元收购药物开发商 Cerevel--消息人士","url":"https://stock-news.laohu8.com/highlight/detail?id=2389069686","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2389069686?lang=zh_cn&edition=full","pubTime":"2023-12-07 05:11","pubTimestamp":1701897077,"startTime":"0","endTime":"0","summary":" David  Carnevali    路透纽约12月6日 - 熟悉内情的人士周三表示，艾伯维公司  即将以约80亿美元的价格收购Cerevel Therapeutics Holdings Inc  ，后者是帕金森等神经系统疾病的药物开发商。消息人士称，艾伯维正在谈判以每股约45美元的价格收购Cerevel公司，该公司得到了私募股权公司贝恩资本的支持。艾伯维和 Cerevel 没有立即回应置评请求。在周三的纽约盘后交易中，Cerevel股价大涨14%至42.20美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2388808317","title":"天价收购ImmunoGen，艾伯维打的什么算盘？","url":"https://stock-news.laohu8.com/highlight/detail?id=2388808317","media":"美股研究社","top":-1,"share":"https://www.laohu8.com/m/news/2388808317?lang=zh_cn&edition=full","pubTime":"2023-12-04 18:04","pubTimestamp":1701684240,"startTime":"0","endTime":"0","summary":"毕竟，这个价格几乎是ImmunoGen 前一天交易价格的两倍。资产负债表上，ImmunoGen 的财产和设备仅有区区 440 万美元。ImmunoGen 拥有原价为 3600 万美元的财产、机械和设备。截至 2023 年第三季度，ImmunoGen 的运营损失为 2100 万美元，如下图所示。目前，ImmunoGen 支付自己的审计师、会计部门、销售人员、保险、人力资源和大量其他管理费用。这表明ImmunoGen现有的产品利润极高。艾伯维的管理层已经做好了充分的准备，而且这次收购ImmunoGen 的时机非常好，具有巨大的回报潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/usstock/c/2023-12-04/doc-imzwwarp7325764.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2023-12-04/doc-imzwwarp7325764.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2388786498","title":"医药生物行业周报：艾伯维重金收购IMMUNOGEN 建议关注ADC相关创新药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2388786498","media":"光大证券股份有...","top":-1,"share":"https://www.laohu8.com/m/news/2388786498?lang=zh_cn&edition=full","pubTime":"2023-12-04 00:00","pubTimestamp":1701619200,"startTime":"0","endTime":"0","summary":"本周观点：艾伯维重金收购ImmunoGen，建议关注ADC 相关创新药企2023 年11 月30 日，艾伯维宣布将收购ADC 公司ImmunoGen，获得其FRα ADC新药Elahere 等，此举强化了艾伯维在ADC 领域的布局。2018 年以来，DS-8201 引领了ADC 研发的新一轮热潮，跨国药企纷纷布局。截至目前，ADC 领域的头部生物技术公司几乎都被跨国药企收入囊中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204152523822b81ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204152523822b81ee&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2388720544","title":"医药行业点评报告：ADC重磅交易再现 艾伯维百亿收购IMMUNOGEN","url":"https://stock-news.laohu8.com/highlight/detail?id=2388720544","media":"太平洋证券股份...","top":-1,"share":"https://www.laohu8.com/m/news/2388720544?lang=zh_cn&edition=full","pubTime":"2023-12-04 00:00","pubTimestamp":1701619200,"startTime":"0","endTime":"0","summary":"事件：11 月30 日，艾伯维宣布，同意以约100亿美元的现金收购新型抗癌疗法抗体偶联药物开发商ImmunoGen 。消息公布后，ImmunoGen 当天收盘价飙升逾80%。根据条款，艾伯维将为每股ImmunoGen 股票支付31.26 美元现金，较前一日收盘价溢价94.6%。艾伯维表示，这项交易预计将于2024 年中期完成。此次收购将加强艾伯维在肿瘤治疗领域的实力ImmunoGen 是ADC 研发领域的老兵，研发的ADC 药物已经有三款获批：Kadcyla,Sarclisa 和Elahere。当专利悬崖迫近，ADC 已成为跨国药企BD 的首选。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204110740822ac4ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204110740822ac4ff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2388472603","title":"艾伯维斥资100亿美元收购Immunogen！ADC药物开发商股价多数走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2388472603","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2388472603?lang=zh_cn&edition=full","pubTime":"2023-12-01 08:20","pubTimestamp":1701390006,"startTime":"0","endTime":"0","summary":"Immunogen周四收涨近83%，艾伯维收涨近3%。其他开发ADC药物的生物科技公司股价同样走高。","market":"sh","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1031965.html","is_publish_highlight":true,"gpt_icon":0},{"id":"2388147248","title":"艾伯维(ABBV.US)斥资100亿美元收购Immunogen(IMGN.US) ADC药物开发商股价多数走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2388147248","media":"老虎证券","top":-1,"share":"https://www.laohu8.com/m/news/2388147248?lang=zh_cn&edition=full","pubTime":"2023-12-01 08:20","pubTimestamp":1701390006,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾伯维周四宣布，以约100亿美元收购新型抗癌疗法抗体偶联药物开发商Immunogen。受此影响，Immunogen周四收涨近83%，艾伯维收涨近3%。其他开发ADC药物的生物科技公司股价同样走高：Sutro Biopharma收涨约13%，Mersana Therapeutics收涨超3%，ADC Therapeutics收涨约8%。此外，专注于中小型生物科技公司的SPDR标普生物技术ETF收涨2%，纳斯达克生物技术指数收涨超1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120108282683c21885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120108282683c21885&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387617440","title":"Immunogen Inc股价飙升81.69% 市值涨63.47亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2387617440","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2387617440?lang=zh_cn&edition=full","pubTime":"2023-11-30 22:31","pubTimestamp":1701354688,"startTime":"0","endTime":"0","summary":"北京时间2023年11月30日22时31分，Immunogen Inc股票出现波动，股价急速拉升81.69%。Immunogen Inc股票所在的生物技术行业中，整体涨幅为0.29%。消息层面，截至22时31分，《盘前涨超81% 癌症制药商Immunogen获艾伯维约100亿美元收购》资讯为影响Immunogen Inc的重要信息。该信息摘要如下：艾伯维周四宣布，已同意以约100亿美元的现金收购新型抗癌疗法抗体偶联药物开发商Immunogen根据条款，艾伯维将为每股ImmunoGen股票支付31.26美元现金，较前一日收盘价溢价94.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023113022312883c04cf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023113022312883c04cf3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387444037","title":"盘前涨超81% 癌症制药商Immunogen(IMGN.US)获艾伯维(ABBV.US)约100亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2387444037","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2387444037?lang=zh_cn&edition=full","pubTime":"2023-11-30 21:39","pubTimestamp":1701351597,"startTime":"0","endTime":"0","summary":"艾伯维周四宣布，已同意以约100亿美元的现金收购新型抗癌疗法抗体偶联药物开发商Immunogen。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20231130/20231130214149_59403.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20231130/20231130214149_59403.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1031870.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2387428494","title":"ImmunoGen(IMGN)盘前暴涨逾80% 艾伯维(ABBV)拟斥资101亿美元收购该公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2387428494","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2387428494?lang=zh_cn&edition=full","pubTime":"2023-11-30 21:28","pubTimestamp":1701350901,"startTime":"0","endTime":"0","summary":"金吾财讯 | 截至发稿，ImmunoGen(IMGN)盘前暴涨超80%，报29美元。消息面上，艾伯维(ABBV)拟以101亿美元的价格收购制ImmunoGen，从而提升其在癌症治疗市场的地位。艾伯维将为每股ImmunoGen股票支付31.26美元现金，较前一日收盘价溢价94.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=92dfc15aa77f65c5c2ed74085eafc9fa","is_publish_highlight":false,"gpt_icon":0},{"id":"1135823551","title":"ImmunoGen盘前暴涨超80%，将被艾伯维收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1135823551","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1135823551?lang=zh_cn&edition=full","pubTime":"2023-11-30 21:23","pubTimestamp":1701350606,"startTime":"0","endTime":"0","summary":"艾伯维将为每股ImmunoGen股票支付31.26美元现金。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":0},{"id":"2387186441","title":"艾伯维(ABBV)拟斥资101亿美元收购ImmunoGen(IMGN)扩大抗癌药物组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2387186441","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2387186441?lang=zh_cn&edition=full","pubTime":"2023-11-30 21:09","pubTimestamp":1701349753,"startTime":"0","endTime":"0","summary":"金吾财讯 | 艾伯维(ABBV)周四表示，它将以101亿美元的价格收购制药商ImmunoGen(IMGN)，从而提升其在癌症治疗市场的地位。艾伯维将为每股ImmunoGen股票支付31.26美元现金，较前一日收盘价溢价94.6%。艾伯维表示，这项交易预计将于2024年中期完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=eae8a9ee811e8d2072a2db629e4cbab9","is_publish_highlight":false,"gpt_icon":0},{"id":"2387449553","title":"更新版 1-艾伯维将斥资 101 亿美元收购 ImmunoGen，以扩大抗癌药物组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2387449553","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2387449553?lang=zh_cn&edition=full","pubTime":"2023-11-30 20:41","pubTimestamp":1701348086,"startTime":"0","endTime":"0","summary":"(全文增加细节)    路透11月30日 - 艾伯维  周四表示，它将以101亿美元的价格收购制药商ImmunoGen  ，从而提升其在癌症治疗市场的地位。这家制药商将为每股ImmunoGen股票支付31.26美元现金，比上次收盘价溢价94.6%。 艾伯维表示，这项交易预计将于2024年中期完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2385494666","title":"Immunogen Inc盘中异动 临近午盘股价大涨5.00%报15.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2385494666","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2385494666?lang=zh_cn&edition=full","pubTime":"2023-11-23 00:48","pubTimestamp":1700671733,"startTime":"0","endTime":"0","summary":"北京时间2023年11月23日00时48分，Immunogen Inc股票出现波动，股价急速上涨5.00%。截至发稿，该股报15.97美元/股，成交量179.195万股，换手率0.67%，振幅5.33%。Immunogen Inc股票所在的生物技术行业中，整体跌幅为0.06%。Immunogen Inc公司简介：Immunogen Inc 是一家来自美国的临床阶段生物技术公司，专注于抗体药物偶联物或 ADC 技术，该技术使用固定在肿瘤细胞上发现的靶标（其抗原）上的抗体来递送特定的抗癌剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231123004854839f1eec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231123004854839f1eec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2384361059","title":"Immunogen Inc盘中异动 大幅拉升5.00%报16.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2384361059","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2384361059?lang=zh_cn&edition=full","pubTime":"2023-11-18 01:43","pubTimestamp":1700242982,"startTime":"0","endTime":"0","summary":"北京时间2023年11月18日01时43分，Immunogen Inc股票出现波动，股价急速拉升5.00%。截至发稿，该股报16.37美元/股，成交量270.734万股，换手率1.02%，振幅4.84%。Immunogen Inc股票所在的生物技术行业中，整体涨幅为1.41%。Immunogen Inc公司简介：Immunogen Inc 是一家来自美国的临床阶段生物技术公司，专注于抗体药物偶联物或 ADC 技术，该技术使用固定在肿瘤细胞上发现的靶标（其抗原）上的抗体来递送特定的抗癌剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231118014302839d90ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231118014302839d90ed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2383047415","title":"Immunogen Inc盘中异动 早盘快速上涨5.09%报15.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2383047415","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383047415?lang=zh_cn&edition=full","pubTime":"2023-11-14 22:30","pubTimestamp":1699972205,"startTime":"0","endTime":"0","summary":"北京时间2023年11月14日22时30分，Immunogen Inc股票出现异动，股价大幅上涨5.09%。Immunogen Inc股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Fresh2 Group Limited、Galera Therapeutics Inc、Immunogen Inc涨幅较大，Biocardia Inc、Tenax Therapeutics Inc、Alaunos Therapeutics Inc较为活跃，换手率分别为206.45%、21.26%、11.15%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Pharvaris Nv、Lava Therapeutics Nv，振幅分别为22.00%、2.97%、1.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111422300584761bd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023111422300584761bd4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2381110842","title":"Immunogen Inc盘中异动 早盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2381110842","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2381110842?lang=zh_cn&edition=full","pubTime":"2023-11-06 22:31","pubTimestamp":1699281067,"startTime":"0","endTime":"0","summary":"北京时间2023年11月06日22时31分，Immunogen Inc股票出现波动，股价大幅下挫5.34%。Immunogen Inc股票所在的生物技术行业中，整体涨幅为1.22%。Immunogen Inc公司简介：Immunogen Inc 是一家来自美国的临床阶段生物技术公司，专注于抗体药物偶联物或 ADC 技术，该技术使用固定在肿瘤细胞上发现的靶标（其抗原）上的抗体来递送特定的抗癌剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231106223107847606e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231106223107847606e8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2380024539","title":"Immunogen Inc盘中异动 下午盘股价大涨5.00%报16.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2380024539","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2380024539?lang=zh_cn&edition=full","pubTime":"2023-11-04 02:22","pubTimestamp":1699035748,"startTime":"0","endTime":"0","summary":"北京时间2023年11月04日02时22分，Immunogen Inc股票出现波动，股价急速拉升5.00%。截至发稿，该股报16.28美元/股，成交量592.151万股，换手率2.38%，振幅6.52%。Immunogen Inc股票所在的生物技术行业中，整体涨幅为0.13%。Immunogen Inc公司简介：Immunogen Inc 是一家来自美国的临床阶段生物技术公司，专注于抗体药物偶联物或 ADC 技术，该技术使用固定在肿瘤细胞上发现的靶标（其抗原）上的抗体来递送特定的抗癌剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311040222288301d8e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311040222288301d8e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2380508957","title":"Immunogen Inc盘中异动 早盘股价大涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2380508957","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2380508957?lang=zh_cn&edition=full","pubTime":"2023-11-02 21:33","pubTimestamp":1698932038,"startTime":"0","endTime":"0","summary":"北京时间2023年11月02日21时33分，Immunogen Inc股票出现异动，股价急速拉升5.82%。Immunogen Inc股票所在的生物技术行业中，整体涨幅为0.54%。Immunogen Inc公司简介：Immunogen Inc 是一家来自美国的临床阶段生物技术公司，专注于抗体药物偶联物或 ADC 技术，该技术使用固定在肿瘤细胞上发现的靶标（其抗原）上的抗体来递送特定的抗癌剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023110221335983e0826e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023110221335983e0826e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunogen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.0586},{"period":"6month","weight":1.1116},{"period":"1year","weight":6.7302},{"period":"ytd","weight":0.0533}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":-0.0299},{"period":"3month","weight":0.0417},{"period":"6month","weight":0.2257},{"period":"1year","weight":0.2254},{"period":"ytd","weight":0.0638}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunoGen, Inc.于1981年在马萨诸塞州组成，专注于基于抗体的抗癌疗法的研发.该公司利用其 专有的抗体药物共轭技术和ADC技术治疗癌症。ADC技术包含一种抗体，ADC一旦绑定目标，该抗体则连接到癌细胞上，结合它的一个强有力的抗癌剂作为“有效载荷”从而杀死癌细胞。ADC是一种治疗癌症的扩展方法，有两种批准治疗方法以及与过去五年相比翻倍的代理数量。","yearOnYearQuotes":[{"month":1,"riseRate":0.485714,"avgChangeRate":0.058335},{"month":2,"riseRate":0.4,"avgChangeRate":0.019916},{"month":3,"riseRate":0.294118,"avgChangeRate":-0.02625},{"month":4,"riseRate":0.441176,"avgChangeRate":0.040179},{"month":5,"riseRate":0.558824,"avgChangeRate":0.055439},{"month":6,"riseRate":0.5,"avgChangeRate":0.057736},{"month":7,"riseRate":0.441176,"avgChangeRate":0.001299},{"month":8,"riseRate":0.470588,"avgChangeRate":0.016012},{"month":9,"riseRate":0.441176,"avgChangeRate":0.012768},{"month":10,"riseRate":0.529412,"avgChangeRate":0.011371},{"month":11,"riseRate":0.588235,"avgChangeRate":0.099293},{"month":12,"riseRate":0.457143,"avgChangeRate":-0.000761}],"exchange":"NASDAQ","name":"ImmunoGen","nameEN":"Immunogen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ImmunoGen(IMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunoGen(IMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunoGen,IMGN,ImmunoGen股票,ImmunoGen股票老虎,ImmunoGen股票老虎国际,ImmunoGen行情,ImmunoGen股票行情,ImmunoGen股价,ImmunoGen股市,ImmunoGen股票价格,ImmunoGen股票交易,ImmunoGen股票购买,ImmunoGen股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunoGen(IMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunoGen(IMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}